Gov. J.B. Pritzker on Friday signed into law a bill that will cap patient costs for insulin at $100 per month for those insured by commercial health plans regulated by the state, in today's bite-sized hospital and health industry news from Florida, Illinois, New Jersey, and Pennsylvania.
- Florida: Nicklaus Children's Hospital has announced that it plans to sell Miami Medical Center in an effort to focus on outpatient clinics and expanding the Nicklaus Children's campus in Coral Terrace. Nicklaus Children's purchased Miami Medical Center two years ago for $88 million. According to Matthew Love, Nicklaus Children's CEO, the hospital has hired a consulting firm to help sell Miami Medical Center's building and the sale has been approved by the hospital's board (Paavola, Becker's Hospital Review, 1/23).
- Illinois: Gov. J.B. Pritzker (D) on Friday signed into law a bill that will cap patient costs for insulin at $100 per month for those insured by commercial health plans regulated by the state. The state's General Assembly approved the bill in November following complaints from diabetes patients about increased out-of-pocket costs for insulin. Some said costs reached as high as $1,000 per month (Associated Press, 1/24).
- New Jersey/Pennsylvania: Geisinger Health on Thursday filed a complaint to sue its affiliate AtlantiCare in an effort to prevent the health system from separating from Geisinger, which AtlantiCare's board voted to do in September 2019. The complaint alleges Michael Charlton, chair of AtlantiCare, and Lori Herndon, CEO of AtlantiCare, violated Geisinger's 2014 agreement to acquire AtlantiCare. The agreement said AtlantiCare could leave Geisinger's health system only if Geisinger was acquired by either a religious nonprofit health system or a for-profit health system, neither of which has occurred. According to the complaint, AtlantiCare in August 2019 alleged Geisinger breached the agreement's terms, which led AtlantiCare to pursue separation from Geisinger (Barr, Modern Healthcare, 1/27).